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OBJECTIVES We sought to determine whether myocardial contrast echocardiography (MCE) performed
before and early after primary coronary stenting (PCS) in patients with acute myocardial
infarction (AMI) could predict recovery of resting left ventricular systolic function and
contractile reserve.
BACKGROUND Myocardial contrast echocardiography can be used to assess perfusion within the risk area
before PCS and the extent of necrosis soon after PCS.
METHODS In 30 patients with AMI, MCE and two-dimensional echocardiography were performed
before PCS and 3 to 5 days and 4 weeks after PCS. Contractile reserve was assessed by
dobutamine echocardiography at four weeks in patients with persistent severe wall-motion
abnormalities.
RESULTS Of segments without perfusion at 3 to 5 days, 95% had severe hypokinesis to akinesis at 4
weeks. Of segments with normal perfusion at 3 to 5 days, 90% had normal wall motion or
mild hypokinesis at 4 weeks, whereas those with partial perfusion at 3 to 5 days were evenly
divided between normal wall motion, hypokinesis, and akinesis. In segments with persistent
severe wall-motion abnormalities at four weeks, contractile reserve was found in 80% of
segments with perfusion, compared with only 10% of segments without detectable perfusion
(p  0.01). The presence of myocardial perfusion by MCE before PCS was associated with
maintained or improved perfusion at 3 to 5 days and eventual recovery of resting wall motion.
CONCLUSIONS Myocardial contrast echocardiography performed early after PCS provides information on the
extent of infarction, and hence the likelihood for recovery of resting systolic function or
contractile reserve. The presence of perfusion before PCS, from either collateral or antegrade
flow, predicts the maintenance of perfusion and recovery of systolic function. (J Am Coll
Cardiol 2003;41:827–33) © 2003 by the American College of Cardiology Foundation
In patients with acute myocardial infarction (AMI), the
primary treatment goal is re-establishment of epicardial
artery patency and restoration of microvascular perfusion.
Prompt and complete microvascular reflow results in salvage
of most of the myocardium at risk and eventual recovery of
resting systolic function. When myocardial salvage is partial,
resting function in the risk area may not recover because
systolic contractile function at rest is dependent largely on
thickening of the endocardial region (1,2). Even when
resting function does not recover, partial viability may still
be beneficial for contractile reserve, exercise tolerance,
prevention of remodeling, and survival (3–6).
The spatial extent of necrosis can be evaluated early after
AMI by myocardial contrast echocardiography (MCE),
which assesses the region of microvascular damage. In this
study, we hypothesized that the extent of viability by MCE
performed early after primary coronary stenting (PCS) in
patients with AMI predicts the degree of recovery of systolic
function; and that in segments with persistent severe wall-
motion abnormalities, the presence of at least partial viabil-
ity by MCE identifies segments with contractile reserve. We
also performed MCE before revascularization to determine
whether the presence of perfusion in the risk area before
PCS, from either collateral flow or antegrade flow in the
infarct-related artery (IRA), predicts restoration of normal
perfusion after PCS and eventual recovery of resting func-
tion.
METHODS
Study design. The study protocol was approved by the
Human Investigation Committee at the University of Vir-
ginia, and all patients gave informed consent. In 30 patients
with ST-segment elevation AMI referred for PCS, MCE
was performed to assess microvascular perfusion, and two-
dimensional (2-D) echocardiography was performed to
assess wall motion immediately before PCS, and 3 to 5 days
and 4 weeks after PCS. In selected patients with persistent
severe wall-motion abnormalities, contractile reserve was
assessed by low-dose dobutamine echocardiography at four
weeks.
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Patient population. Consecutive patients with ST-
elevation AMI presenting within 8 h of symptom onset
referred for primary PCS were enrolled. The diagnosis of
AMI was made on the basis of symptoms consistent with
myocardial ischemia for 30 min and 2 mm ST-segment
elevation in two or more contiguous electrocardiogram
leads. Patients with a history of prior AMI, wall-motion
abnormalities in more than one vascular territory on the
initial echocardiogram, cardiomyopathy, hemodynamic in-
stability, or allergy to blood products were excluded.
Coronary angiography and stenting. All patients received
oral aspirin (324 mg) and intravenous heparin. Angiography
was performed using standard views. Coronary angioplasty
and stenting (3.0 to 4.5 mm diameter) of the IRA was
performed and deemed successful in all patients. Clopi-
dogrel (300 mg) was given orally before PCS and continued
(75 mg per day) for the duration of the study. Intravenous
glycoprotein IIb/IIIa antagonist was administered at the
discretion of the operating physician. The Thrombolysis In
Myocardial Infarction (TIMI) flow grade (7) before and
following PCS was assessed by a reader blind to clinical and
echocardiographic data.
MCE. Intermittent ultraharmonic imaging was performed
using a Sonos 5500 ultrasound system (Philips Ultrasound,
Andover, Massachusetts) with transmission and receive
frequencies of 1.3 and 3.6 MHz, respectively. Images were
acquired in the apical two-, three-, and four-chamber views.
The maximal mechanical index was used and the acoustic
focus was placed at the level of the mitral valve and adjusted
to the apex when needed to exclude near-field artifacts. A
dynamic range of 60 dB was used and compression was set
at 80. For each patient, settings were kept constant for all
stages.
After acquisition of baseline images, Optison (Mallinck-
rodt Medical, St. Louis, Missouri) was administered intra-
venously as a continuous infusion (0.5 ml·min1) and
adjusted to produce optimal opacification without far-field
attenuation. After several beats of continuous imaging,
end-systolic images were acquired at pulsing intervals (PI)
of every 1 to 10 cardiac cycles to allow incremental replen-
ishment of microbubbles into the tissue in the ultrasound
imaging sector following each high-power pulse (8).
2-D and dobutamine echocardiography. Wall motion
was assessed by 2-D echocardiography with and without
contrast enhancement of the left ventricular cavity in the
apical two-, three-, and four-chamber imaging planes. Wall
motion was assessed using tissue harmonic imaging before
contrast infusion. At the end of each microbubble infusion
performed for assessment of perfusion, settings were opti-
mized for left ventricular cavity opacification by decreasing
the mechanical index to 0.4 to 0.5, placing the acoustic
focus at the apex, and adjusting the gain settings as needed.
For assessment of contractile reserve at four weeks, wall
motion was assessed during infusion of incremental doses of
dobutamine from 5 to 20 g·kg1·min1 during continuous
electrocardiogram and blood pressure monitoring. Cine
loops were acquired at frame rates 30 Hz.
Data analysis. Analysis of echocardiographic data was
performed by an experienced reader blind to the clinical and
angiographic data. Myocardial contrast echocardiography
and wall motion data were assessed separately. For each
view, the left ventricle was divided into six equal segments.
Resting wall motion in each segment was scored as 1 
normal, 2  mild hypokinesis, 3  severe hypokinesis, 4 
akinesis, or 5  dyskinesis based on review of the noncon-
trast and contrast-enhanced video clips. Segments that were
severely hypokinetic to dyskinetic on the initial study before
PCS constituted the risk area. For each study, a wall motion
score index in the risk area (WMSI-RA) was derived by
summing all wall motion scores in the risk area and dividing
by the total number of segments. In selected patients with
persistent severe wall motion abnormalities (WMSI-RA
2.5 and at least two segments with scores 3) at four
weeks, the presence of contractile reserve was defined by an
improvement of 1 grade during dobutamine infusion,
except for dyskinetic segments, which were considered
viable only if a score of 3 was achieved.
Myocardial perfusion was assessed from MCE images
obtained during intermittent ultraharmonic imaging. Each
segment was assigned a single perfusion score based on both
the change in myocardial signal intensity with prolongation
of the PI and the degree of opacification at the longest PI.
Scores were graded as 2  normal (homogenous opacifica-
tion approximating that of the normal region at longest PI
and normal rate of increase in signal with PI prolongation),
1 reduced (partial or reduced opacification compared with
the normal region at the longest PI and/or reduced rate of
increase in signal intensity with PI prolongation), or 0 
absent (no opacification despite prolongation of the PI). A
perfusion score index in the risk area (PSI-RA) was derived
by dividing the summed perfusion scores in the risk area by
the number of segments. Segments in which perfusion could
not be assessed because of attenuation or other imaging
artifacts were excluded from analysis for both WMSI-RA
and PSI-RA. One-third of all studies were randomly chosen
to assess interobserver variability with a second expert
reader.
Statistical methods. Data are expressed as the mean 
SD. Comparisons were made using the Student t test
(paired) or by chi-square analysis. The relationship between
Abbreviations and Acronyms
AMI  acute myocardial infarction
IRA  infarct-related artery
MCE  myocardial contrast echocardiography
PCS  primary coronary stenting
PI  pulsing interval
PSI-RA  perfusion score index in the risk area
TIMI  Thrombolysis In Myocardial Infarction
2-D  two-dimensional
WMSI-RA  wall motion score in the risk area
828 Balcells et al. JACC Vol. 41, No. 5, 2003
MI and Viability by Contrast Echocardiography March 5, 2003:827–33
WMSI-RA and PSI-RA data was analyzed by regression
analysis and data were curve-fitted using a least-squares fit.
The R value was derived from R2 or the regression sum of
squares divided by the total sum of squares. Differences were
considered significant at p  0.05.
RESULTS
Patient characteristics and clinical variables. The clinical
variables for the patient cohort are presented in Table 1.
Antegrade flow in the IRA was found in 40% of patients by
arteriography before PCS. Stenting was successful in re-
establishing epicardial artery patency in all patients and 87%
had angiographic TIMI-3 flow after the procedure. There
were no deaths or clinical evidence for recurrent ischemic
events (rehospitalization for angina or acute coronary syn-
drome, or repeat coronary angiography) in the four-week
interval after PCS.
Temporal course of myocardial perfusion. In the studies
randomly chosen to assess interobserver variability, concor-
dance between the two readers was good for both segmental
wall motion scores (92% concordance, kappa  0.91) and
perfusion scores (82% concordance, kappa  0.60). Discor-
dance was attributable mostly to wall motion scores assigned
as 3 versus 4, and for perfusion scores assigned 1 versus 2.
The perfusion scores on MCE for segments within the
risk area assessed 3 to 5 days after PCS according to their
perfusion scores before PCS are shown in Figure 1. In the
68 segments with no perfusion (score  0) before PCS, 51
(75%) had restoration of perfusion (score  1 or 2) at 3 to
5 days. Myocardial contrast echocardiography images dem-
onstrating almost complete restoration of myocardial per-
fusion in the risk area after PCS are illustrated in Figure 2.
In the 156 risk area segments with partial or normal
perfusion (score  1 or 2) before PCS, 147 (94%) had
improved or maintained perfusion at 3 to 5 days, the
majority of which was categorized as normal (Fig. 1),
whereas only 9 (6%) demonstrated absence of perfusion. Of
segments with perfusion before PCS, 45% were in patients
who had spontaneous reflow of their IRA on angiography
before PCS, whereas the remainder were in patients with
occluded arteries. Segmental perfusion scores at 4 weeks
were almost identical to those at 3 to 5 days, with differences
found in only 14 of 227 segments (6%) within the risk area.
Myocardial perfusion and recovery of resting systolic
function. Wall-motion scores within the risk area 4 weeks
after PCS according to MCE-derived myocardial perfusion
3 to 5 days after PCS are depicted in Figure 3A. Almost all
segments without perfusion (score  0) at 3 to 5 days had
severe wall motion abnormalities at 4 weeks, approximately
75% of which were akinetic or dyskinetic. Almost all
segments with normal perfusion (score  2) at 3 to 5 days
had normal wall motion or were only mildly hypokinetic at
4 weeks. The majority of these segments (62%) had com-
pletely normal wall motion. In segments with partial per-
fusion (score 1) at 3 to 5 days, wall motion at 4 weeks was
evenly divided between normal wall motion, mild hypoki-
nesis, severe hypokinesis, and akinesis.
Table 1. Clinical and Angiographic Data
Age (median, yrs) 58
Gender (male/female) 20/10
Hypertension, n (%) 16 (53%)
Diabetes, n (%) 6 (20%)
Hyperlipidemia, n (%) 10 (30%)
Time from symptom onset (h) 4.9  1.9
Totally occluded IRA, n (%) 18 (60%)
Infarct artery, n (%)
LAD 12 (40%)
RCA 16 (53%)
LCx 2 (7%)
Postprocedural TIMI-3 flow, n (%) 26 (87%)
GP IIb/IIIa inhibitor, n (%) 24 (80%)
GP  glycoprotein; IRA  infarct-related artery; LAD  left anterior descending
coronary artery; LCx  left circumflex; RCA  right coronary artery; TIMI 
Thrombolysis In Myocardial Infarction.
Figure 1. Perfusion scores for segments within the risk area assessed by
myocardial contrast echocardiography 3 to 5 days after primary coronary
stenting (PCS) according to their perfusion scores assessed immediately
before PCS. p  0.01 for differences between the groups by chi-square
analysis. Perfusion score at 3 to 5 days: white bar  0; striped bar  1;
black bar  2.
Figure 2. Examples of myocardial contrast echocardiography images in the
apical four-chamber plane illustrating near complete myocardial reperfu-
sion in a patient undergoing successful primary coronary stenting (PCS) of
a totally occluded left anterior descending coronary artery (LAD). Images
were obtained at a pulsing interval of 10 cardiac cycles and demonstrate
little perfusion in the LAD territory before PCS (left image) and
restoration of perfusion except for a small portion of the distal septum at 3
to 5 days (right image).
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Because the likelihood of maintaining normal microvas-
cular perfusion after PCS was much greater when perfusion
was present before PCS (Fig. 1), we investigated whether
perfusion before PCS predicted eventual recovery of wall
motion. The relation between myocardial perfusion in
segments within the risk area before PCS and wall motion
at four weeks is depicted in Figure 3B. Almost all segments
with normal perfusion and the majority of segments with
partial perfusion had normal wall motion or were mildly
hypokinetic at four weeks.
The relation between the PSI-RA 3 to 5 days after PCS
and the WMSI-RA at 4 weeks is depicted in Figure 4.
Those patients with excellent perfusion in the risk area
(high PSI-RA) after PCS had near complete recovery of
wall motion (low WMSI-RA), whereas patients with very
poor perfusion did not recover function. The relation for all
patients was, however, nonlinear owing to lack of recovery
of wall motion (high WMSI-RA) in those with an inter-
mediate degree of perfusion in the risk area after PCS.
Illustrated in Figure 5 are end-systolic MCE images ob-
tained from a patient with an intermediate PSI-RA and
persistent akinesis in much of the risk area. These images
suggest that subendocardial or patchy infarction was respon-
sible for lack of recovery of resting wall motion in patients
with intermediate perfusion scores.
Myocardial perfusion and contractile reserve. To deter-
mine whether the presence of viability detected by MCE
confers contractile reserve in patients whose resting function
did not recover, wall motion response to dobutamine was
assessed. A subset of 9 patients with a PSI-RA of 0 to 1.5
at 3 to 5 days and a WMSI-RA 2.5 at 4 weeks (patients
represented by the initial plateau in Fig. 4) were selected for
dobutamine echocardiography. Augmentation in systolic
thickening occurred in almost all risk area segments where
perfusion was present, and occurred in few segments where
perfusion was absent (Fig. 6). For the few segments where
contractile reserve was observed despite no perfusion, the
risk area was very small, and bordering segments always had
normal perfusion.
DISCUSSION
In this study we have demonstrated that in patients with
AMI the extent of microvascular integrity assessed by MCE
early after primary percutaneous intervention provides in-
formation on myocardial viability. The new information
provided by this study includes: 1) that the extent of
recovery of resting systolic function correlates with the
extent of perfusion by MCE; 2) that in regions with
persistent severe wall motion abnormalities, the presence of
patchy or epicardial viability identifies regions with contrac-
tile reserve; and 3) that the presence of perfusion within the
risk area before PCS, from either collateral flow or sponta-
neous reperfusion of the IRA, is associated with small
regions of infarction indicated by eventual recovery of
resting systolic function.
Myocardial contrast echocardiography is well suited for
assessing the integrity of the microcirculation and, hence,
for determining the extent of myocardial necrosis early after
AMI (9). Before the development of intravenous ultrasound
Figure 3. Wall-motion scores in segments within the risk area 4 weeks
after primary coronary stenting (PCS) according to (A) perfusion score at
3 to 5 days, and (B) perfusion score before PCS. p  0.01 for differences
between all groups by chi-square analysis for both A and B. Wall-motion
score at 4 weeks: white bar  1 to 2; black bar  3 to 5.
Figure 4. Relationship between the perfusion score index in the risk area
(PSI-RA) assessed by myocardial contrast echocardiography 3 to 5 days
after primary coronary stenting and the wall motion score index in the risk
area (WMSI-RA) at 4 weeks.
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contrast agents, microbubbles were injected directly into the
coronary artery during angiography to assess the distal
capillary bed. In the current study, intravenous microbubble
administration and intermittent high-power imaging algo-
rithms were used to evaluate regional perfusion, and viability
was determined by analyzing both the peak intensity at a
long PI and the change in acoustic intensity with prolon-
gation of the PI (10). Assessment of viability with MCE
was delayed for several days after PCS because microvascu-
lar perfusion in the risk area immediately after epicardial
artery reflow is dynamic because of hyperemia (11), and
because microvascular reflow can substantially improve or
worsen in the first few hours or days after epicardial artery
reflow (12). We found that perfusion assessed 3 to 5 days
after PCS was almost identical to that measured later in the
chronic phase.
In patients with acute or recent AMI, the absence of
microvascular perfusion determined by MCE with intra-
coronary injection of microbubbles predicts lack of recovery
of resting left ventricular systolic function, irrespective of
whether IRA patency is achieved (13–15). More recent
studies using intravenous contrast administration and inter-
mittent high-MI imaging techniques have shown similar
results (16–20). In accord with prior studies, we found that
resting wall motion invariably did not recover when myo-
cardial perfusion was absent after PCS. In prior studies,
however, the presence of perfusion by MCE early after
AMI has not been completely reliable for predicting recov-
ery of resting function (17,18,21). These findings do not
necessarily imply a weakness in the imaging technique, but
instead reflect the expected long-term outcomes when there
is subendocardial or patchy infarction. Wall motion at rest
is largely dependent upon endocardial thickening so that the
transmural extent of viability in some of these studies may
not have been sufficient to allow recovery of systolic function
(1,2). In the current study, we determined on a segmental
basis that the presence of completely normal perfusion at 3
to 5 days after PCS predicted the presence of normal or
near-normal function at 4 weeks. When perfusion was
present but reduced, reflecting partial infarction, resting wall
motion at four weeks was variable. Many of these segments
where resting function remained severely hypokinetic to
akinetic were characterized by an epicardial rim of viable
tissue.
Even when resting systolic function does not recover, the
presence of partial viability after AMI is likely to be
beneficial. Although mid- and epicardial portions of the left
ventricle contribute little to resting function, they become
important for augmentation of systolic performance during
exertion. In patients with chronic ischemic dysfunction,
revascularization of viable territories leads to improvement
in inotropic reserve even when resting akinesia persists (5).
Accordingly, we sought to determine whether the presence
of viability in segments with persistent severe wall-motion
abnormalities after primary revascularization identifies the
ability to augment thickening with stress. Contractile re-
serve was measured by low-dose dobutamine echocardiog-
raphy in the relatively small number of patients with poor
wall-motion scores at four weeks. Almost all segments with
perfusion had a positive inotropic response, whereas very
few segments without perfusion improved. Our results are
in accord with a recent report demonstrating that the degree
of opacification on MCE (for the entire risk area rather than
a segmental basis) correlated with the presence of contractile
reserve in patients with recent AMI (21).
Figure 5. End-systolic myocardial contrast echocardiography images in the apical four-chamber view obtained 3 to 5 days after primary coronary stenting
illustrating a subendocardial perfusion defect (arrows) in a region with akinesis at rest. The background image (left image) was obtained before contrast
administration whereas the contrast-enhanced image (right image) was obtained at a pulsing interval of every eight cardiac cycles.
Figure 6. Percent of segments demonstrating a positive inotropic response
to dobutamine at 4 weeks according to perfusion score at 3 to 5 days. p 
0.01 for differences between all groups by chi-square analysis.
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The presence of viability in the epicardial portions of the
left ventricle overlying the infarct bed is also beneficial for
maintaining normal left ventricular shape and preventing
adverse left ventricular remodeling (22). Left ventricular
dilation after AMI has been shown to occur primarily in
patients who have little or no contractile response to
dobutamine (6), or who have complete absence of micro-
vascular reflow by MCE with intracoronary injection of
microbubbles (23). Hence, it is likely that patients in our
study with persistent severe wall motion abnormalities but
partial viability after PCS would be protected from adverse
remodeling. We believe that more patients and longer
follow-up would be required to adequately test this hypothesis.
In patients undergoing primary angioplasty, the presence
of TIMI-3 epicardial artery flow before the procedure
portends better prognosis in terms of mortality and devel-
opment of congestive heart failure (24). This benefit is
presumably due to preserved microvascular perfusion and
enhanced myocardial salvage. In the current study, we
demonstrated that microvascular perfusion in the risk area
before PCS predicted postprocedural viability and recovery
of resting function. Many of these segments were found in
patients in whom antegrade flow was detected in the IRA
before PCS. The ability of MCE to predict TIMI 2 or 3
flow in the IRA before PCI has been demonstrated previ-
ously (20). However, MCE can also be used to assess
collateral-derived myocardial blood flow, manifest by con-
trast enhancement that occurs at long PIs (25,26). It is,
therefore, not surprising that perfusion in the risk area
before PCS was also detected in a group of patients with
completely closed infarct-related arteries. The presence of
perfusion within the risk area, even when reduced compared
to normal regions, portended a better prognosis in terms of
perfusion status after intervention and recovery of resting
systolic function. Loss of perfusion after PCS in segments
that had normal perfusion before the procedure, presumably
a result of distal microvascular embolization, was uncommon.
Methods for quantifying myocardial perfusion by contrast
echocardiography are currently available that rely on the
assessment of myocardial microvascular blood volume and
blood velocity (8). Although quantification may have
yielded more objective and reproducible data, it would have
limited the clinical relevance of the study for several reasons.
First, the means for quantifying perfusion by analyzing PI
versus acoustic intensity data are currently not widely
applied in the clinical setting. Second, quantification pro-
tocols in their current form are time consuming and are
unlikely to be used when integrating information on perfu-
sion acquired in the acute setting before PCS.
In summary, results of this study indicate that the extent
of myocardial salvage can be determined by MCE early after
PCS at a time when viability cannot be accurately assessed
by contractile function because of postischemic stunning.
Recovery of resting left ventricular function can no longer be
considered the gold standard for assessing viability because
this parameter does not detect salvage of epicardial portions
of the myocardium, which may be important for maintain-
ing left ventricular geometry, providing contractile reserve,
and preventing heart failure symptoms. Myocardial contrast
echocardiography is capable of detecting partial viability
even in territories that remain akinetic, thereby providing
information on prognosis and need for further protection
from ischemic injury. Because MCE perfusion imaging can
be performed rapidly at the patient bedside, it also provides
the opportunity to evaluate myocardial blood flow in pa-
tients with AMI before intervention. With the evolving
paradigms of transferring patients to regional AMI treat-
ment centers for percutaneous intervention, it is possible
that this information will prove valuable for determining
optimal treatment strategies for individual patients.
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